Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression.

Ngollo M, Lebert A, Daures M, Judes G, Rifai K, Dubois L, Kemeny JL, Penault-Llorca F, Bignon YJ, Guy L, Bernard-Gallon D

Open source

DOI: 10.1186/s12885-017-3256-y
Published: 2017 Apr 12
Container: BMC cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12885-017-3256-y,
  title = {Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression.},
  author = {Ngollo M and Lebert A and Daures M and Judes G and Rifai K and Dubois L and Kemeny JL and Penault-Llorca F and Bignon YJ and Guy L and Bernard-Gallon D},
  year = {2017},
  journal = {BMC cancer},
  doi = {10.1186/s12885-017-3256-y},
  url = {https://doi.org/10.1186/s12885-017-3256-y}
}

RIS

TY  - JOUR
TI  - Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression.
AU  - Ngollo M
AU  - Lebert A
AU  - Daures M
AU  - Judes G
AU  - Rifai K
AU  - Dubois L
AU  - Kemeny JL
AU  - Penault-Llorca F
AU  - Bignon YJ
AU  - Guy L
AU  - Bernard-Gallon D
PY  - 2017
JO  - BMC cancer
DO  - 10.1186/s12885-017-3256-y
UR  - https://doi.org/10.1186/s12885-017-3256-y
ER  -

APA

M, N., A, L., M, D., G, J., K, R., L, D., JL, K., F, P., YJ, B., L, G., & D, B. (2017). Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression.. BMC cancer. https://doi.org/10.1186/s12885-017-3256-y

Source records

pubmed · retrieved 2026-09-26T06:51:06.850Z